Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Descamps

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|January 1, 1981
Effects of E-5-(2-bromovinyl)-2'-deoxyuridine and other selective anti-herpes compounds on the induction of retrovirus particles in mouse BALB/3T3 cellsE De Clercq, H Heremans, J Descamps, et al.
Developments in Biological Standardization|November 24, 1999
Release potency tests of hepatitis vaccinesJ Descamps, A Mary, E Rommel, et al.
Journal of Medicinal Chemistry|May 1, 1983
Nucleic acid related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosidesE De Clercq, J Descamps, J Balzarini, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetesFrancis J Descamps, Philippe E Van den Steen, Inge Nelissen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1982
Influence of (E)-5-(2-bromovinyl)-2'-deoxyuridine on corneal epithelium healingP C Maudgal, N De Kimpe, E De Clercq, et al.
Journal of Medicinal Chemistry|March 1, 1979
5-Substituted uracil arabinonucleosides as potential antiviral agentsP F Torrence, G F Huang, M W Edwards, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2003
Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulinFrancis J Descamps, Philippe E Van den Steen, Erik Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1979
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agentE De Clercq, J Descamps, P De Somer, et al.
Nucleic Acids Symposium Series|January 1, 1980
The synthesis and properties of some 5-substituted uracil derivativesR T Walker, A S Jones, E De Clercq, et al.
British Medical Journal|November 1, 1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zosterE de Clercq, H Degreef, J Wildiers, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|January 1, 1981
Effects of E-5-(2-bromovinyl)-2'-deoxyuridine and other selective anti-herpes compounds on the induction of retrovirus particles in mouse BALB/3T3 cellsE De Clercq, H Heremans, J Descamps, et al.
Developments in Biological Standardization|November 24, 1999
Release potency tests of hepatitis vaccinesJ Descamps, A Mary, E Rommel, et al.
Journal of Medicinal Chemistry|May 1, 1983
Nucleic acid related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosidesE De Clercq, J Descamps, J Balzarini, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetesFrancis J Descamps, Philippe E Van den Steen, Inge Nelissen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1982
Influence of (E)-5-(2-bromovinyl)-2'-deoxyuridine on corneal epithelium healingP C Maudgal, N De Kimpe, E De Clercq, et al.
Journal of Medicinal Chemistry|March 1, 1979
5-Substituted uracil arabinonucleosides as potential antiviral agentsP F Torrence, G F Huang, M W Edwards, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2003
Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulinFrancis J Descamps, Philippe E Van den Steen, Erik Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1979
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agentE De Clercq, J Descamps, P De Somer, et al.
Nucleic Acids Symposium Series|January 1, 1980
The synthesis and properties of some 5-substituted uracil derivativesR T Walker, A S Jones, E De Clercq, et al.
British Medical Journal|November 1, 1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zosterE de Clercq, H Degreef, J Wildiers, et al.
Pageof 8